Guidelines for the management of basal cell carcinoma


  • Conflicts of interest
    C.A.M. has received honoraria for speaking and has organized educational events as well as conducted research during the past 5 years from/for Galderma. He has also received travel support from 3M Pharmaceuticals.

N.R. Telfer.


This article represents a planned regular updating of the previous British Association of Dermatologists guidelines for the management of basal cell carcinoma. These guidelines present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis and investigation.